Melanoma Reagents | abinScience

Inicio > Productos Destacados > Oncology Research > Melanoma

960 resultados de producto para "Melanoma"

Opciones+

Opciones

Confirmar

Tipos de productos

0 seleccionado

Stable Cell Lines (1)

Assay Kit (419)

Proteins (75)

Biosimilars (1)

Research Biosimilar (157)

Antibodies (298)
Sistema de expresión

0 seleccionado

HEK293T (1)

E. coli (35)

Mammalian Cells (186)
Objetivo

0 seleccionado

IDO1 (2)

CD366/TIM-3 & CD279/PD-1 (2)

Sarilumab (2)

CD152/CTLA4 & CD279/PD-1 (1)

HLA-A2-peptide (ITDQVPFSV) Complex (4)

EGFR & CD3E & PD-L1 & 4-1BB (1)

CD366/TIM-3 & CD274/PD-L1 (1)

TRP-1 & CD47/MER6 (1)

CD274/PD-L1 & CD279/PD-1 (1)

Oleclumab (1)

Imalumab (1)

Semaglutide (2)

Ascrinvacumab (1)

TFF3 (1)

Tislelizumab (1)

Disitamab (1)

Pacmilimab (1)

TDP2 (1)

Marstacimab (1)

Daratumumab (3)

gD/US6 (1)

Basiliximab (1)

Elezanumab (1)

Apamistamab (1)

Ranibizumab (3)

NP/Nucleoprotein (3)

Tavolimab (1)

Secukinumab (2)

Imlifidase (5)

Olokizumab (1)

Foravirumab (1)

CD47/MER6 & CD274/PD-L1/B7-H1 (2)

Ocaratuzumab (1)

Elotuzumab (1)

Cusatuzumab (1)

TPP47 (1)

Drozitumab (1)

Ontamalimab (1)

Eldelumab (1)

Sacituzumab (1)

Eculizumab (3)

Varlilumab (1)

Tirzepatide (2)

gp100 peptide-HLA Complex (1)

Teclistamab (1)

Mirzotamab (1)

CD223 (1)

Emactuzumab (1)

M1R (5)

Human β Amyloid (1-40) (1)

CD274/PD-L1 & TGFBR2/TGFR-2 (1)

CD80/B7-1 & CD86/B7-2 (2)

S100A11 (2)

HLA-A2-peptide (YLEPGPVT) Complex (4)

Calprotectin (S100A8/9) (3)

BRAF/B-Raf (5)

Mavezelimab (1)

CD137/4-1BB & CD274/PD-L1 (3)

TRP-1 & CD134/OX40 (1)

TAU pT181 (1)

Evolocumab (1)

EPO/Erythropoietin (1)

Lupartumab (1)

Toripalimab (1)

Exenatide acetate (2)

Pertuzumab (3)

CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)

Denosumab (3)

US8/gE (1)

Sibrotuzumab (1)

Fluorescein & CD274/PD-L1 (1)

Camidanlumab (1)

Mazdutide (2)

RBD (6)

Varisacumab (1)

RBD (Omicron/JN.1) (1)

Lirilumab (1)

CTLA4 & PD1 (2)

Tesidolumab (1)

Sirukumab (1)

Rafivirumab (1)

cAMP (1)

RBD (WT) (1)

Vorsetuzumab (1)

G/Major surface glycoprotein G (1)

Lexatumumab (1)

Mirikizumab (2)

PDL1 (6)

Aflibercept (1)

Ipilimumab (2)

GP/Envelope glycoprotein (4)

T3E (1)

Golimumab (3)

Omburtamab (1)

Zampilimab (1)

NRAS (2)

CD175/Tn (10)

S100A6 (1)

Omalizumab (2)

HLA-A2-peptide (KTWGQYWQV) Complex (2)

Favezelimab (1)

CD86/B7-2 (26)

CD152/CTLA4 & CD274/PD-L1 (1)

Cixutumumab (1)

H3L (3)

TAU pT217 (1)

Andecaliximab (1)

Alirocumab (1)

Cinpanemab (1)

CD274/PD-L1 & CD28 (1)

TYR/Tyrosinase (2)

Trastuzumab (2)

Nirsevimab (1)

CD47/MER6 & PDCD1 / PD-1 / CD279 (1)

Obinutuzumab (2)

Cetuximab (3)

Ifabotuzumab (1)

CD366/HAVCR2/TIM-3 (4)

Spike glycoprotein E2 (2)

Simlukafusp Alfa (1)

LAG3 & PD-1 (1)

Daclizumab (1)

Enfortumab (1)

Emibetuzumab (1)

RBD (Delta) (3)

FLT1/VEGFR1 & CD274/PD-L1 (1)

RBD (Omicron/KP.2) (1)

Tibulizumab (1)

Ziltivekimab (1)

VASH2/Vasohibin-2 (1)

Carlumab (1)

RBD (Alpha) (1)

N/Nucleoprotein (1)

Tigatuzumab (1)

Glembatumumab (1)

Lenzilumab (1)

Semorinemab (1)

Talacotuzumab (1)

S100A5 (4)

Tremelimumab (1)

gG/US4 (2)

T-cell surface antigen T3/Leu-4 epsilon chain (1)

Pasotuxizumab (1)

TIGIT & CD274/PD-L1 (1)

Anifrolumab (1)

S100a15a (1)

CD152/CTLA4 & CD134/OX40 (1)

Rituximab (1)

CD274/PD-L1 & CD137/TNFRSF9 (1)

S100A12 (1)

S100A14 (1)

CD274/PD-L1 (81)

T-cell surface glycoprotein CD3 epsilon chain (1)

Rosopatamab (2)

Infliximab (2)

Frovocimab (1)

Dalotuzumab (1)

E8L (5)

S100A2 (1)

Depatuxizumab (1)

Retatrutide (1)

Zanidatamab (1)

Palivizumab (3)

KITLG/SCF (1)

Afutuzumab (1)

sCD14 (1)

CD366/TIM-3 (34)

Spike glycoprotein E1 (2)

Spike glycoprotein (10)

Crizanlizumab (1)

CD340/ERBB2 (1)

Codrituzumab (1)

Tanezumab (1)

Vunakizumab (1)

Tosatoxumab (1)

SOX10 (3)

RBD (Beta) (1)

Meplazumab (1)

Balstilimab (1)

Namilumab (1)

Dilpacimab (1)

Tilavonemab (1)

Natalizumab (2)

S100A8 (3)

Vibecotamab (1)

Zalifrelimab (1)

gB/Envelope glycoprotein B (1)

CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)

S100A1 (2)

Vofatamab (1)

CD223/LAG3 & CD279/PD-1 (4)

Abatacept (1)

S100A13 (1)

S100A4 (3)

CD274/PD-L1 & CD152/CTLA4 (1)

Indatuximab (1)

S100B (9)

CD223/LAG3 (41)

CD279/PD-1 & CD274/PD-L1 (1)

gE/Envelope glycoprotein E (1)

Tarextumab (1)

Lodelcizumab (1)

PD-L1 & VEGF (1)

Figitumumab (1)

A35R (5)

Farletuzumab (1)

Ustekinumab (3)

CD79B (2)

Losatuxizumab (1)

Afasevikumab (1)

β-D-Glucan (1)

Suptavumab (1)

B7-H1 / PD-L1 / CD274 & CD3E (1)

Epcoritamab (1)

F/Fusion glycoprotein F0 (5)

Letolizumab (1)

dsRNA (1)

Ibalizumab (1)

Ianalumab (1)

Tocilizumab (3)

Spike Protein (Trimer) (2)

Dupilumab (3)

Inclacumab (1)

IL1RL1/ST2 (1)

VSIR/VISTA & CD274/PD-L1 (1)

Cergutuzumab (1)

cGMP (1)

Lorvotuzumab (1)

RBD (Gamma) (1)

MITF (1)

Cetrelimab (1)

DCT (2)

Otilimab (1)

Navicixizumab (1)

VEGFA & B7-H1 / PD-L1 / CD274 (1)

Zagotenemab (1)

p-Tyr (1)

Icrucumab (1)

CD152/CTLA4 (86)

CD274/PD-L1 & TGFBR2 (1)

CD279/PD-1 & CD152/CTLA4 (4)

CD274/PD-L1 & CD3E (1)

Sotrovimab (1)

MLANA (4)

Edrecolomab (1)

gD/Envelope glycoprotein D (1)

Urelumab (1)

Canakinumab (1)

LAG-3 & PD-1 (1)

Ganitumab (1)

A29L (6)

Mirvetuximab (1)

B6R/SL-159 (1)

CD274/PD-L1/B7-H1 (5)

Necitumumab (1)

Bimekizumab (1)

Zenocutuzumab (1)

Glofitamab (1)

Guselkumab (3)

ATP7B (1)

Benufutamab (1)

Amatuximab (1)

Tregalizumab (1)

PD-L1 & TGF-Beta (1)

NP/Nucleocapsid (5)

dsDNA (1)

Astegolimab (1)

Adalimumab (3)

Tiragolumab (2)

Labetuzumab (1)

Obiltoxaximab (1)

BSA (1)

RBD (E484K) (1)

Alacizumab (1)

Faricimab (1)

Nivolumab (3)

Atezolizumab (3)

CD274/PD-L1 & CD47/MER6 (1)

CD274/PD-L1 & SLT-Ia (1)

CD80/B7-1 (20)

Oxelumab (1)

TRP-1 & CD3e (1)

S100P (1)

CD223/LAG3 & CD152/CTLA4 (1)

S100A10 (4)

Lintuzumab (1)

mitF/aspF1 (1)

Milatuzumab (1)

Avelumab (3)

Befovacimab (1)

Casirivimab (1)

Bimagrumab (1)

gC/Envelope glycoprotein C (1)

Utomilumab (1)

Gevokizumab (1)

Tezepelumab (1)

Teprotumumab (1)

IL6 (1)

Bevacizumab (3)

SARS-CoV-2 Neutralization Antibody (3)

Ivuxolimab (1)

PDL1 & VEGF (1)

Panitumumab (3)

Ixekizumab (1)

Siltuximab (3)

Suvizumab (1)

CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)

Ibritumomab (1)

RBD (Omicron/BA.4/BA.5) (1)

CD278/ICOS (1)

Itolizumab (1)

TPP15 (1)

Anetumab (1)

Zanolimumab (1)

Blosozumab (1)

Lacnotuzumab (1)

Iscalimab (1)

Olaratumab (1)

Glycoprotein (5)

PMEL17/ME20M (9)

Protein A (1)

Tisotumab (1)

RBD (Kappa) (1)

Ramucirumab (1)

Nesvacumab (1)

Pembrolizumab (3)

Asp f 1/mitF (1)

CD274/PD-L1 & CD134/OX40 (1)

CD274/PD-L1 & CD28 & CD152/CTLA4 (1)

CD47/MER6 & CD274/PD-L1 (2)

S100A16 (1)

HLA-A2-peptide (TDQVPFSV) Complex (1)

Ieramilimab (1)

CD274/PD-L1 & VEGFA (1)

TYRP1 (3)

CD19 & PD-L1 & CD3E & CD137 (1)

S100A9 (4)

Spike glycoprotein (RBD) (1)

Vanucizumab (1)

Sintilimab (1)

Glycoprotein G (2)

Durvalumab (3)

CD80&IL2 (1)

Concizumab (1)

Imdevimab (1)

CD117/KIT (24)

Rolinsatamab (1)

gC/UL44 (1)

Magrolimab (1)

CD20/MS4A1 (3)

Etanercept (3)

Brolucizumab (1)

RBD (Omicron/BA.5) (3)

Pogalizumab (1)

Serclutamab (1)

Remtolumab (1)

Clazakizumab (1)

Mosunetuzumab (1)

TPP17 (1)

Conatumumab (1)

Romosozumab (1)

TYR (1)

Romiplostim (2)

Tovetumab (1)

M/Matrix protein (2)

CD3E (1)

Belantamab (1)

PD-L1 / VEGF-A (1)

Certolizumab (2)

Enoblituzumab (1)

Cabiralizumab (1)

Gremubamab (1)

Human β Amyloid (1-42) (1)

RBD (Delta Plus) (1)
Especies

0 seleccionado

Tupaia chinensis (12)

Mus musculus (Mouse) (7)

Homo sapiens (Human) (7)

Canis lupus familiaris (Dog) (8)

Dog (3)

Human (178)

Felis catus (Cat) (9)

Cat (1)

Mouse (27)

Neosartorya fumigata (1)

Canis lupus familiaris (1)

Rat (1)
Aplicaciones

0 seleccionado

IF (8)

Functional assay (6)

Bioactivity testing in progress (31)

Research in vivo (4)

Blocking (2)

Neutralization (2)

ELISA (844)

in vivo CTLA-4 neutralization (2)

GICA (2)

FCM (152)

IHC (84)

in vivo (2)

in vivo intra-tumoral regulatory T cell depletion (2)

in vivo blockade (2)

Neut (1)

FuncS (18)

Inhib (1)

WB (165)

IFA (4)

Bioactivity: FACS (153)

in vivo PD-L1 blockade (3)

SPR (4)

IP (2)

Functional assay (158)

in vitro PD-L1 blockade (3)

SDS-PAGE (75)

Bioactivity: FACS (1)

Research in vivo (158)

IHC-F (3)

FACS (5)

Inmunógeno (75)
Reactividad

0 seleccionado

Neosartorya fumigata (1)

Drosophila willistoni (1)

Homo sapiens (Human) (4)

Monkey (5)

Kirsten murine sarcoma virus (1)

Cat (1)

Kryptolebias marmoratus (1)

Avian retrovirus IC10 (1)

Carassius auratus (1)

Chicken (4)

Limanda limanda (1)

Avian rous-associated virus type 1 (1)

Tupaia chinensis (4)

Cavia porcellus (1)

Pig (6)

Mesocricetus auratus (1)

Bos taurus (8)

Coturnix japonica (1)

Mouse (78)

Cynomolgus monkey (1)

Dog (13)

Human (198)

Pongo abelii (2)

Cyprinus carpio (1)

Callithrix jacchus (1)

Monodelphis domestica (1)

Oryctolagus cuniculus (4)

Rhesus macaque (1)

Mus musculus (Mouse) (1)

B7-H1 / PD-L1 / CD274 (1)

Danio rerio (1)

Capra hircus (1)

Oryzias latipes (1)

Drosophila grimshawi (1)

Broad-Spectrum (1)

Xenopus laevis (1)

Macaca mulatta (1)

Bovine (1)

Rat (16)
Especie huésped

0 seleccionado

Humanized (34)

Alpaca (6)

HEK293T (1)

Human (157)

Dog (2)

Mouse (164)

Armenian Hamster (5)

Rabbit (61)

Chimeric (5)

Rat (14)
Clonalidad

0 seleccionado

Monoclonal (398)

Polyclonal (53)
Conjugado

0 seleccionado

FITC (28)

APC (28)

PerCP (28)

Unconjugated (301)

PE (28)